drugset / Trial / NCT00868764

An Investigation on the Effect of Age and BMI on the Pharmacokinetics of Transdermal Granisetron

NCT00868764

Phase 1 Completed 60 enrolled Kyowa Kirin, Inc.
NaSingle-groupOpen-labelOther

Summary

This study aims to evaluate the effect of age and BMI on the pharmacokinetics and safety of Sancuso®.

Timeline

Start
2009-04
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Granisetron Other / unclassified 3.1 mg Other

Indications

No indication recorded.